Dasatinib-induced renal (or chronic) thrombotic microangiopathy in a patient with chronic myeloid leukemia: A case report
Open Access
- 1 January 2025
- journal article
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 13
Abstract
Thrombotic microangiopathy encompasses microvascular thrombosis, hemolytic anemia, thrombocytopenia, and end-organ damage. Secondary thrombotic microangiopathy can result from malignancies, autoimmune diseases, or treatments such as tyrosine kinase inhibitors. Dasatinib, a tyrosine kinase inhibitor used in managing chronic myeloid leukemia, has been linked to thrombotic microangiopathy. This report describes a 66-year-old female with chronic myeloid leukemia treated with dasatinib who developed renal-limited thrombotic microangiopathy. Progressive renal dysfunction found in the context of chronic kidney disease prompted extensive lab evaluation and evaluation, with a renal biopsy confirming thrombotic microangiopathy attributed to dasatinib-induced nephrotoxicity. Discontinuation of dasatinib led to a slight improvement in renal function; however, progressive decline necessitated dialysis. This case underscores the diagnostic and therapeutic challenges of dasatinib-induced thrombotic microangiopathy, emphasizing renal biopsy in diagnosis and monitoring. Individualized treatment strategies and further research should be conducted to optimize future outcomes.Keywords
This publication has 23 references indexed in Scilit:
- The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoringThrombosis Research, 2015
- A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injuryBlood Reviews, 2015
- Nephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literaturePediatric Nephrology, 2013
- Atypical Hemolytic Uremic SyndromeSeminars in Nephrology, 2013
- Renal Arteriolar C4d DepositionTransplantation, 2013
- Dasatinib-Induced Nephrotic-Range ProteinuriaAmerican Journal of Kidney Diseases, 2013
- A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinibLeukemia Research Reports, 2013
- Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathyBlood, 2011
- Acute Renal Failure under Dasatinib TherapyRenal Failure, 2010
- The molecular and biochemical characterization of mutant monoclonal antibodies with increased antigen bindingThe Journal of Immunology, 1991